Tempus AI, Inc. Class A Common Stock
About: Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Employees: 2,400
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
397% more first-time investments, than exits
New positions opened: 164 | Existing positions closed: 33
162% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 29
114% more funds holding in top 10
Funds holding in top 10: 7 [Q4 2024] → 15 (+8) [Q1 2025]
83% more funds holding
Funds holding: 155 [Q4 2024] → 284 (+129) [Q1 2025]
69% more call options, than puts
Call options by funds: $582M | Put options by funds: $344M
63% more capital invested
Capital invested by funds: $1.75B [Q4 2024] → $2.85B (+$1.11B) [Q1 2025]
1.43% more ownership
Funds ownership: 33.92% [Q4 2024] → 35.35% (+1.43%) [Q1 2025]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Guggenheim Subbu Nambi | 32%upside $75 | Buy Maintained | 30 Jun 2025 |
B of A Securities Michael Ryskin | 23%upside $70 | Neutral Maintained | 25 Jun 2025 |
Piper Sandler David Westenberg | 23%upside $70 | Neutral Maintained | 15 May 2025 |
Morgan Stanley Tejas Savant | 14%upside $65 | Overweight Maintained | 9 May 2025 |
Needham Ryan MacDonald | 23%upside $70 | Buy Reiterated | 7 May 2025 |
Financial journalist opinion
Based on 87 articles about TEM published over the past 30 days









